CEDAR

1/3: Our latest quarterly bulletin is now available! 🗞️

In this issue, we are delighted to announce the appointment of Kathleen Withers as our new Director. Kathleen steps into the role following 15 years with the team, most recently serving as Deputy Director. 👏

We also extend a huge thank you to Dr Rhys Morris for his leadership and compassion over the last 5 years.

Happy International Day of Women and Girls in Science from CEDAR! 👩‍🔬

We wanted to take a moment today to celebrate the brilliant women on our team. We are so proud of our group, made up of evaluation scientists, trial managers, health economists, qualitative researchers, analysts, translators, and administrators.

A massive thank you to our own team, and to all the amazing women in the groups we collaborate with👏❤️

#WomenInScience #CEDARCardiff

Are you living in Wales and taking HRT for menopausal symptoms?

CEDAR are conducting a survey to evaluate the care you receive from NHS Wales, specifically focusing on treatment reviews.

Your feedback will help us understand what works well and what needs to change.

The survey takes approx 10 mins. It is funded by Value Transformation (@Valuein_Health)

For more information or to take part, visit the survey Link: lnkd.in/eA_75WJ3

Help shape the future of menopause care in Wales. 💜

CEDAR is evaluating how HRT reviews are handled across NHS Wales. Your feedback will help national bodies understand how to improve services for everyone.

Have your say here: lnkd.in/eA_75WJ3

#MenopauseSupport #HRT #PatientVoice #Cymru

Our Principal Health Economist, Megan Dale, Senior Researcher, Katherine Woolley and Sophie Frankel from @DHCWales joined global experts last week in Glasgow at #ISPOREurope2025, to discuss the latest in Health Economics and Outcomes Research (HEOR).

​They showcased four key pieces of research conducted by CEDAR:
🔹 SROI in Healthcare: Highlighting methodological opportunities and challenges when attempting to value what matters to stakeholders.
🔹 Medical Device Assessment: Methodologies and challenges of Network Meta-Analysis (Drug-Eluting Stents case study for @NICEComms).